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Comparison of Hospital Readmission for Carotid Interventions
Colleen S. Hupp, Robin L. Kruse, PhD, W. Kirt Nichols, MD, Viktor Y.
Dombrovskiy, PhD, and Todd R. Vogel, MD. University of Missouri
Hospitals and Clinics, Columbia, MO; and UMDNJ, New Brunswick, NJ
Objective: Interventions for carotid artery disease are typically well
tolerated and involve an overnight admission. Few studies have evaluated
rates of readmission in the Medicare population comparing less invasive
carotid artery stenting (CAS) with traditional open carotid endarterectomy
(CEA). The objective of this study was to evaluate readmission rates after
CEA and CAS and identify predictors of readmission.
Methods: MedPAR data (2005-2009) were used to select patients
who underwent CEA or CAS according to International Classification of
Diseases-9th Edition-Clinical Modification codes. Readmission within 30,
60, and 90 days from time of procedure was determined. Sociodemographic
characteristics and Elixhauser comorbidity measures were used to adjust for
confounding. Patients who received CEA and CAS were compared with 2
and multivariable logistic regression analysis.
Results: A total of 235,247 carotid interventions were performed
(211,118 CEA and 24,129 CAS). Readmission rates for CEA and CAS
patients, respectively, were 8.84% and 11.11% at 30 days (P  .0001),
13.31% and 17.98% at 60 days (P  .0001) and 16.86% and 22.68% at 90
days (P  .0001). Less than half of patients were women (43%) and were
more likely to be readmitted during 30 days after discharge (P .001). After
adjustment for age, race, gender, comorbidities, and procedure, patients
aged 80 years (odds ratio [OR], 1.25; 95% confidence interval [CI],
1.20-1.30) and patients with renal failure (OR, 1.6; 95% CI, 1.56-1.73),
congestive heart failure (OR, 1.6; 95% CI, 1.57-1.73), or diabetes (OR, 1.4;
95% CI, 1.27-1.52) were more likely to be readmitted. In addition, patients
who underwent CAS were 1.2 times as likely to be readmitted (95% CI,
1.15-1.25) as patients who received CEA. Diagnoses at readmission were
similar between groups.
Conclusions: Interventions for carotid artery disease had a high overall
readmission rate. After adjustment for comorbidities, use of less invasive
techniques (CAS) was not associated with decreased readmission. Patients
who underwent CAS were more likely to be readmitted than those who
received CEA at 30, 60 and 90 days. Predictors of readmission included
advanced age, congestive heart failure, renal failure, and diabetes. Further
research is needed to determine strategies to reduce hospital readmission
rates after carotid interventions.
Contemporary Outcomes After Distal Vertebral Reconstruction
Dawn M. Coleman, MD, Andrea Obi, MD, Enrique Criado, MD, Shipra
Arya, MD, and Ramon Berguer, MD, PhD. Department of Surgery,
Section of Vascular Surgery, University of Michigan, Ann Arbor, Mich
Objectives: Flow-limiting lesions or embolic phenomena can both
produce vertebrobasilar ischemia. This study aims to differentiate the patho-
physiology of vertebral ischemia and examine contemporary outcomes of
distal vertebral reconstruction.
Methods: Thirty-seven consecutive distal vertebral artery (VA) recon-
structions were performed in 34 patients between February 2005 and
November 2011, including bypass to the third portion of the VA (V3) at the
C1-2 level (n  24) or the C0-1 level (n  4); transposition of the external
carotid artery or its occipital branch onto V3 (n  6); transposition of V3
onto the internal carotid artery (n  3); and bypass from the ipsilateral
subclavian artery to V3 (n 1). Five patients required a concomitant carotid
intervention, and three patients required a partial resection of the C1
transverse process. Symptoms, present in 94% of patients, were attributed to
a flow-limiting lesion in 75% (n 24) and to embolization in the remaining
25% (n  8).
Results: Intraoperatively, five patients required graft revision or con-
version of a transposition to a bypass and two patients required vertebral
ligation. Median blood loss was 238 mL. Hospital length of stay averaged 2
days. Postoperatively, one patient required re-exploration for bleeding
(2.7%), and one patient suffered stroke (2.7%). Two patients had cranial
nerve injury (5.4%). There was no perioperative mortality. After a mean
follow-up of 28 months, 91% of patients experienced symptom improve-
ment. Of the 28 patients who underwent follow-up imaging, cumulative
primary patency was 83%, cumulative primary-assisted patency was 93%, and
cumulative secondary patency was 97% (Fig). There were two late deaths of
unknown etiology and no late strokes identified.
Conclusions: Distal VA reconstruction for flow-limiting or embolic
lesions provides excellent long-term patency and stroke protection.
Functional Analysis of Mesenchymal Stem Cells in Ischemic
Conditions
Victor C. Njoku, MD, Reza Saadatzadeh, PhD, Andrea L. Jester, MD, and
Michael P. Murphy, MD. Department of Surgery, Indiana University
School of Medicine, Indianapolis, Ind
Objectives: Mesenchymal stem cells (MSCs) are currently used clini-
cally in cell-based therapies to treat critical limb ischemia via intramuscular
injection, an environment characterized by hypoxia, elevated levels of oxi-
dative stress, and inflammation. In this investigation we compared MSCs
from various tissue sources to assess sensitivity in various in vitro assays that
may predict potency in vivo.
Methods:MSCs from adult bone marrow (BM-MSCs), adipose tissue
(ASCs), and term placenta (P-MSCs) were isolated and characterized using
culture assays and flow cytometry. MSCs were exposed to hydrogen perox-
ide (H2O2), tumor necrosis factor- (TNF-), and hypoxic conditions (1%
oxygen). MSCs were analyzed based on the rate of apoptosis, senescence,
overall survival, and vascular network formation. Apoptosis was measured by
annexin V expression via flow cytometry. Expression of -galactosidase was
detected by light microscopy to quantify senescence. Overall survival was
measured via spectrophotometer detection of methylene blue staining.
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Vascular networks were created with endothelial colony-forming cells de-
rived from cord blood.
Results: MSCs from various tissue sources demonstrated appropriate
stem cell markers via flow cytometry. P-MSCs exhibited increased apoptosis
in response to H2O2 compared with ASCs and BM-MSCs (P .001). ASCs
demonstrated increased apoptosis after exposure to TNF- and hypoxia
compared with MSCs (P  .001). No difference in senescence activity was
detected by various MSCs. ASCs demonstrated elevated overall survival in
response to H2O2 (P  .05). BM-MSCs and P-MSCs exhibited increased
survival after exposure to TNF- and hypoxia (P .001). ASCs exhibited no
difference in tube formation after exposure to H2O2 compared with con-
trols. However, ASCs exhibited significant decreases in mean tube length
after exposure to TNF- and hypoxic conditions compared with controls
(P  .05).
Conclusions: ASCs remain potent under oxidative stress conditions,
whereas P-MSCs and BM-MSCs thrive under inflammatory and hypoxic
conditions. This report outlines how MSCs respond to various conditions
unique to vascular injury and indicate that ASCs may be the optimal cell
source in critical limb ischemia, because oxidative stress is the dominant
factor determining cell viability in this condition.
Clinical Evaluation of Suspected DVT Guides the Decision to Prophy-
lactically Anticoagulate but Does Not Impact the Decision to Perform
After-Hours Duplex Venous Scanning or Increase Its Yield
Michael R. Go, MD, Dennis Kiser, Patrick Wald, Mounir J. Haurani, MD,
Mark Moseley, MD, and Bhagwan Satiani, MD. Department of Surgery,
The Ohio State University, Columbus, Ohio
Objectives: The utility of after-hours duplex venous scanning (DVS)
for suspected DVT in emergency department (ED) patients has been de-
bated. Availability of safe, prophylactic, low-molecular-weight heparin, cost
containment efforts, and retention of scarce sonographers have to be bal-
anced against 24/7 demand for services. We determined the incidence of
DVT in DVS ordered after hours, correlation between the Wells score and
prophylactic anticoagulation, as well as urgently performed DVS, and com-
plications of delaying DVS until regular hours.
Methods: Records of all ED encounters between July 1, 2009 and
June 30, 2010 associated with a DVS ordered after hours were reviewed.
The decisions to prophylactically anticoagulate andwhether to performDVS
urgently or delayed until regular hours were at the discretion of the ED
physician and a vascular surgeon. DVS findings, number of urgent and
delayed studies, the Wells scores, D-dimer levels, and outcomes were re-
corded.
Results: DVT was found in 12% (n  22) of 181 DVS ordered after
hours. DVT was found in 19% of 42 DVS done urgently and in 10% of 139
DVS delayed an average 10 hours 17 minutes (P  NS). Wells scores were
available for all patients and D-dimer levels for 43 (Table). Seventy-eight
percent of patients with a Wells score 3 had prophylactic anticoagulation,
whereas only 40% of patients with a Wells score 3 had prophylactic
anticoagulation (P .0001). In contrast, 36% of patients with a Wells score
 3 had urgent DVS and 20% of patients with a Wells’ score3 had urgent
DVS (p  ns). Prophylactic anticoagulation was given to 86% of patients
eventually found to have DVT versus 40% of patients eventually found to
have no DVT (P  .0001). There were no PEs or bleeding complications.
Conclusions: The incidence of DVT in ED patients who had urgent
after hours DVS was no different than in those whose DVS was delayed until
regular hours. High pretest probability can be achieved with clinical evalu-
ation prior to DVS, and this guided the decision to prophylactically antico-
agulate but did not impact the decision to perform urgent DVS. Most
patients eventually found to have DVT did receive prophylactic anticoagu-
lation, and delay of DVS did not result in complications. We believe that
most patients in whom there is high clinical suspicion for DVT can safely get
prophylactic anticoagulation and delayed DVS. Patients in whom there is
low clinical suspicion should not get urgent DVS.
Table. Wells score and D-dimer results
Variable Wells score  3 (%) D-dimer (%)
Sensitivity 64 100
Specificity 88 17
Positive predictive value 42 9
Negative predictive value 95 100
Asymptomatic 50% to 75% Internal Carotid Artery Stenosis in 288
Patients: Risk Factors for Disease Progression and Ipsilateral Neuro-
logic Symptoms
Anahita Dua, MD, Bhavin Patel, SreyRam Kuy, MD, Gary Seabrook, MD,
Kellie Brown, MD, Brian Lewis, MD, and Peter Rossi, MD. Medical
College of Wisconsin, Milwaukee, Wisc
Objectives: This study evaluated the safety of an observation protocol
in asymptomatic patients with moderate internal carotid artery stenosis, and
to identify characteristics associated with disease progression.
Methods: Patients with asymptomatic moderate internal carotid dis-
ease (peak systolic velocity [PSV]  125 cm/s and end diastolic velocity
[EDV] 125 cm/s by duplex ultrasound imaging) correlating to 50% to
75% diameter reduction were monitored for 3 years. Progression to greater
than 75% diameter reduction (EDV 125 cm/s) or presentation with focal
neurologic symptoms (stroke, amaurosis fugax, transient ischemic attack)
was documented. Comorbidities, smoking status, and medications were
recorded. Log-rank testing, Wilcoxon models, and Kaplan-Meier plots
provided statistical analysis.
Results: During follow up, 26 of 288 patients (9%; 137 men, 151
women) developed symptoms (stroke: 9 [3.1%]; transient ischemic attack: 3
[1%]; amaurosis fugax: 3 [1%]), or asymptomatic increase in diameter to
75% (11 patients [3.8%]). All-cause mortality was 11% (33 patients).
Seventeen patients (5.9%) underwent carotid endarterectomy and five
(1.7%) had carotid stent placement. The event incidence was significantly
higher for men (P .02), but survival was not different. The rate of disease
progression or development of symptoms was 5.5% at 12 months and
increased to 7.2% by 24 months. Comorbidities with the highest associated
event incidences were coronary artery disease (8.1%), hyperlipidemia (7.3%),
and hypertension (6.7%). Medications associated with lower event inci-
dences were insulin (2.8%) and angiotensin-receptor blockers (1.9%).
Conclusions: Sequential surveillance of asymptomatic patients with
moderate carotid disease is safe, with only 5% becoming symptomatic and 4%
having disease progression. Male patients with coronary artery disease,
hyperlipidemia, and hypertension are at increased risk and are candidates for
frequent screening and/or early intervention.
Deep Venous Thrombosis After Saphenous Endovenous Radiofre-
quency Ablation: Is It Predictable?
Maria C.Mora, MD, Peter JBHunt, MD, Jennifer Orozco, Chad E. Jacobs,
MD, Aksim Rivera, MD, and Walter J. McCarthy, MD. Rush University
Medical Center, Chicago, Ill
Objectives: Endovenous radiofrequency ablation (RFA) is a safe and
effective treatment for varicose veins secondary to saphenous reflux. Deep
venous thrombosis (DVT) is a known complication of this procedure. The
purpose of this study is to describe the frequency of DVT after RFA and
associated predisposing factors.
Methods: We performed a retrospective data analysis from December
2008 to December 2011, during which 277 consecutive office-based RFA
were performed in our institution using the VNUS ClosureFast catheter.
Duplex scans were completed 2 weeks postprocedure in all patients to
confirm saphenous vein obliteration and evaluate the deep venous system for
thrombosis. Risk factors assessed for development of DVT included greater
vs lesser saphenous, side treated, number of cycles used, hypercoagulable
state, history of DVT, tobacco use, medications (oral contraceptives, aspirin,
warfarin, clopidogrel), and vein diameter at the junction of the superficial
and deep systems.
Results: Seventy percent of the patients were female, 56% were right
side, and 86% were performed on the greater saphenous vein. Mean age was
54  14 (range, 23-88 years). 3% of patients had a diagnosis of hypercoag-
ulable state and 8% had a history of DVT. Follow-up ultrasound imaging
showed thrombus protrusion into the deep system without occlusion was
present in 11 patients (4%). DVT, as defined by thrombus protrusion with
complete occlusion of the femoral or popliteal vein, developed in two
patients (0.7%). PreviousDVTwas the only factor associated withDVT (P
.018). Although not statistically significant, there was a trend toward higher
risk of DVT in LSV patients. Factors associated with protrusion into the
deep system were lesser saphenous vein (P  .035), and factor V Leiden
(P  .026).
Conclusions: The use of RFA to treat patients with saphenous reflux
involves a small but definite risk of DVT. This study demonstrates that the
risk of DVT or any thrombus protrusion in to the deep system is greater in
patients with previous DVT, factor V Leiden, and treatment of the lesser
saphenous vein. Periprocedural anticoagulation should be considered in this
subset to reduce the risk of complication after RFA.
Response of Neointimal Hyperplasia and the Adventitial Sca1 Stem
Cell to Nitric Oxide
Nathaniel C. Koo, MD, George E. Havelka, MD, Janet Martinez, Megan
Flynn, and Melina R. Kibbe, MD. Northwestern University, Chicago, Ill
Objectives:Recently, Sca1 stem cells have been identified to reside in
the adventitia of the arterial wall. However, their role in the formation of
neointimal hyperplasia is unknown, as is the effect of nitric oxide (NO) on
these cells. We hypothesize that Sca1 stem cells contribute to neointimal
development and that NO limits the involvement of adventitial Sca1 cells
in the arterial injury response, thereby inhibiting neointimal hyperplasia.
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